You just read:

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Biologix FZCO for Contrave® (naltrexone HCl / bupropion HCl prolonged release) for Ten Countries in the Middle East

News provided by

Orexigen Therapeutics, Inc.

19 Dec, 2016, 08:10 ET